ARPO
Aerpio Pharmaceuticals Inc
Halal Rating :
Last Price
$3.00
Last updated:
Market Cap
-
7D Change
-0.66%
1 Year Change
78.57%
Company Overview
Exchange
Next Earnings Date
Note: Aerpio Pharmaceuticals Inc (ARPO) merged with Aadi Bioscience in August 2021 and now operates as Aadi Bioscience Inc (AADI).
Aadi Bioscience is a biopharmaceutical company focused on developing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Their lead product candidate is FYARRO™ (nab-sirolimus), which targets specific mutations in the mTOR pathway.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $7.21m | $20.66m | - | $38000.0 | 0.00% | 0.18% |
| June 30, 2024 | $6.18m | $21.82m | - | $58000.0 | 0.00% | 0.27% |
| March 31, 2024 | $5.35m | $24.92m | - | $58000.0 | 0.00% | 0.23% |
Company Impact
Help us evaluate Aerpio Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.